HYPERCHOLESTEROLEMIA

This study is testing whether drinking a specific brand of no-sugar-added soymilk daily can help lower cholesterol levels in adults. It will enroll 50 healthy adults aged 18-65 who have high total cholesterol. Participants will drink two bottles of soymilk every day for 8 weeks w…

This study is testing a new drug called SHR-1918 for adults with high cholesterol that remains too high despite taking two types of standard medications (statins and PCSK9 inhibitors). Researchers will give 126 participants either the new drug or a placebo (inactive shot) to see …

This study tests whether community health workers can help people better manage multiple chronic conditions like diabetes, high blood pressure, and heart disease. 300 adults with at least two chronic health conditions will work with trained health coaches for 9 months to develop …

This study aims to see if a combination of three cholesterol-lowering drugs can shrink and stabilize fatty plaque buildup in the heart's arteries. It will enroll about 103 adults who have this plaque but have not yet had a heart attack or stroke. Researchers will use special hear…

This study is testing if a cholesterol-lowering drug called alirocumab is safe and effective when given as a weekly injection instead of the usual schedule. It will involve 420 adults with high cholesterol. Researchers will measure how much the drug lowers 'bad' cholesterol and t…

This study aims to see if sending simple electronic information letters can encourage adults with heart disease to get their cholesterol checked and better manage their risk factors. It will involve 100,000 people in Denmark who will either receive these reminder letters or not, …

This small pilot study is testing whether carefully managing two common health issues—high blood pressure and high cholesterol—can help prevent dementia in people who are genetically at risk. It will enroll 10 adults aged 50-75 who carry a specific gene linked to higher dementia …

This study looks back at real-world data to see how well patients in Japan with high cholesterol stick to their prescribed injection treatments over one year. It compares two different injectable medications, inclisiran and evolocumab, to see which one patients are more likely to…